Kit ELISA Matrix MetalloProteinase 8 sandwich (Hu MMP8) (human): quantitative determination of Hu MMP8 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu MMP8.
Kit ELISA Matrix MetalloProteinase 8 sandwich (Hu MMP8) (human): quantitative determination of Hu MMP8 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu MMP8.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
Matrix metalloprotease 8 (MMP8) is also known as neutrophil collagenase or collagenase 2. MMP8 degrades fibrillar collagens of types I, II, III, l ́agrecane, serpines and l ́alpha-2 macroglobulin. All collagenases cleave fibrillar collagen at a specific site, resulting in the generation of fragments at three quarters of the N-terminal end and one quarter of the C-terminal end, which then denate into gelatin at body temperature. The specificity of collagenase substrate is variable: MMP1 degrades collagen type III more effectively than collagen type I or II, whereas MMP8 is more potent in degraden type I than collagen type III or type II. MMP13, in turn, degrades collagen type II 6 times more effectively than collagens type I and II and has almost 50 times greater gelatinlytic activity than MMP1 and MMP8. MMP8 is very similar to MMP1, as they share 57% of the amino acid identity. Most cell types do not produce MMP8. Until recently, MMP8 was thought to be exclusively produced by neutrophils, but was also detected in other types of cells, including arthritic chondrocytes and gingival fibroblasts. The human gene MMP8 has a chromosome location of 11q22.2-22.3.
Sensitivity
Sensitivity of the dosage: 6 pg/ml.
Measurement range
Dose range: 8.23 pg/ml to 6.000 pg/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Samples
Sample type: Plasma, Serum, Surnatant (plasma volume, 50 μl; serum, 50 μl; supernatant, 100 μl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17195509 |
| Specifications |
| Accession number | P22894 |
| Dose range | 8.23 pg/ml to 6.000 pg/ml |
| Sensitivity of the dosage | 6 pg/ml |
| Calibration range | 6 pg/ml to 6 000 pg/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Cell structure & organic proteins |
| Type of sample | Plasma, Serum, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with any of the cytokines tested: angiopoietin-1 human, angiostatin, B7-1, BMP-7, CD14, CD30, CD40, CD40 ligand, CTLA-4, CXCL16, Dkk-4, DR6, endostatin, E-selectin, follistatin, HB-EGF, HVEM, ICAM-2, IGF-II, IL-10 Ra, IL-10 Rb, IL-18, IL-9, IL |
| Sufficient for | 5 x 96 dosages |
| Target species | Human |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 4317 |
| Gene symbol(s) | MMP8 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | Wash pad, Biotinylated detection antibody, Dose diluent concentrate, Calibration, SAV-HRP, Adhesive plate covers, Chromogen, Pre-coated 96-well plates, Stop solution |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | RUO |
| Research disciplines | Extracellular Matrix & Cell Adhesion |
| Synonym | CLG1, HNC, MMP-8, PMNL-CL |
| Target | Human |
| Test time | 1 hour 20 minutes. |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; serum, 50 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4:45 a.m. |
Origin and customs
| Manufacturer ref. | EHMMP8X5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.